This week the Senate Health, Education, Labor and Pensions Committee passes the Pharmaceutical Compounding Quality and Accountability Act, which differentiates between traditional compounding pharmacies and compounding manufacturers, according to the American Society of Anesthesiologists.
Compounding manufacturers are defined as companies that repackage preservative-free sterile products or make sterile products without a prescription to sell them across state lines.
If passed, the bill would submit these manufacturers to federal rules, rather than the state regulations of traditional pharmacies. ASA is monitoring the safety concerns associated with this bill, including the production of drugs in short supply.
More Articles on Anesthesia:
Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
Facilities Should Renew Efforts to Have Disaster Procedures in Place
WPAH Appoints Dr. Ahmed Badr to Anesthesiology Chair
Compounding manufacturers are defined as companies that repackage preservative-free sterile products or make sterile products without a prescription to sell them across state lines.
If passed, the bill would submit these manufacturers to federal rules, rather than the state regulations of traditional pharmacies. ASA is monitoring the safety concerns associated with this bill, including the production of drugs in short supply.
More Articles on Anesthesia:
Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
Facilities Should Renew Efforts to Have Disaster Procedures in Place
WPAH Appoints Dr. Ahmed Badr to Anesthesiology Chair